H Albín

603 total citations
66 papers, 451 citations indexed

About

H Albín is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Toxicology. According to data from OpenAlex, H Albín has authored 66 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 14 papers in Pediatrics, Perinatology and Child Health and 9 papers in Toxicology. Recurrent topics in H Albín's work include Antibiotics Pharmacokinetics and Efficacy (20 papers), Pharmacovigilance and Adverse Drug Reactions (9 papers) and Pharmaceutical studies and practices (8 papers). H Albín is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (20 papers), Pharmacovigilance and Adverse Drug Reactions (9 papers) and Pharmaceutical studies and practices (8 papers). H Albín collaborates with scholars based in France and Greece. H Albín's co-authors include F. Demotes‐Mainard, Bernard Bégaud, Françoise Haramburu, Bernard Bégaud, Fabienne Péhourcq, M Amouretti, J.M. Ragnaud, A M Taburet, Isabelle Landru and E Singlas and has published in prestigious journals such as The American Journal of Cardiology, Clinical Pharmacology & Therapeutics and Journal of Antimicrobial Chemotherapy.

In The Last Decade

H Albín

64 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Albín France 12 205 94 76 75 67 66 451
James A. Visconti United States 13 115 0.6× 105 1.1× 65 0.9× 48 0.6× 29 0.4× 39 636
Hans Liedholm Sweden 20 75 0.4× 196 2.1× 68 0.9× 71 0.9× 31 0.5× 47 911
F. Demotes‐Mainard France 13 180 0.9× 43 0.5× 47 0.6× 39 0.5× 18 0.3× 41 383
M. G. Bogaert Belgium 13 135 0.7× 89 0.9× 60 0.8× 22 0.3× 40 0.6× 22 481
Anthony R. Temple United States 17 83 0.4× 90 1.0× 190 2.5× 48 0.6× 31 0.5× 33 684
Glen D. Park United States 16 180 0.9× 136 1.4× 151 2.0× 37 0.5× 83 1.2× 27 1.1k
Pim N.J. Langendijk Netherlands 16 242 1.2× 88 0.9× 124 1.6× 127 1.7× 41 0.6× 25 1.1k
L. Merle France 10 96 0.5× 60 0.6× 64 0.8× 30 0.4× 15 0.2× 31 543
D W Holt United Kingdom 14 113 0.6× 88 0.9× 44 0.6× 68 0.9× 114 1.7× 48 768
M.L'E. Orme United Kingdom 22 173 0.8× 136 1.4× 265 3.5× 38 0.5× 25 0.4× 39 960

Countries citing papers authored by H Albín

Since Specialization
Citations

This map shows the geographic impact of H Albín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Albín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Albín more than expected).

Fields of papers citing papers by H Albín

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Albín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Albín. The network helps show where H Albín may publish in the future.

Co-authorship network of co-authors of H Albín

This figure shows the co-authorship network connecting the top 25 collaborators of H Albín. A scholar is included among the top collaborators of H Albín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Albín. H Albín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Puozzo, C., et al.. (1998). Pharmacokinetics of milnacipran in liver impairment. European Journal of Drug Metabolism and Pharmacokinetics. 23(2). 273–279. 22 indexed citations
2.
Abalan, F., et al.. (1990). Effect of posture on total phenytoin plasma concentration. European Journal of Clinical Pharmacology. 38(5). 526–527. 2 indexed citations
3.
Demotes‐Mainard, F., et al.. (1989). Pharmacokinetics of a New Macrolide, Roxithromycin, in Infants and Children. The Journal of Clinical Pharmacology. 29(8). 752–756. 5 indexed citations
4.
Albín, H, et al.. (1989). Micro-method for the determination of roxithromycin in human plasma and urine by high-performance liquid chromatography using electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 490(1). 115–123. 24 indexed citations
5.
Demotes‐Mainard, F., et al.. (1988). Micromethod for determination of ceftriaxone in plasma and urine by high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 6(4). 407–413. 10 indexed citations
6.
Bromet, Norbert, et al.. (1988). Pharmacokinetics of rilmenidine in healthy subjects. The American Journal of Cardiology. 61(7). D47–D53. 11 indexed citations
7.
Bègué, P, et al.. (1987). Pharmacokinetics of roxitharomycin in paediatrics. Journal of Antimicrobial Chemotherapy. 20(suppl B). 101–106. 13 indexed citations
8.
Demotes‐Mainard, F., et al.. (1987). Micromethod for the determination of cefpiramide in human plasma and urine by high-performance liquid chromatography using automated column switching. Journal of Chromatography B Biomedical Sciences and Applications. 419. 388–395. 8 indexed citations
9.
Demotes‐Mainard, F., et al.. (1986). [Pharmacokinetics of prednisolone in renal transplant patients with or without Cushing's syndrome].. PubMed. 41(6). 449–54. 1 indexed citations
10.
Bégaud, Bernard, et al.. (1986). Computerized comparison of six adverse drug reaction assessment procedures. Clinical Pharmacology & Therapeutics. 40(4). 451–461. 37 indexed citations
11.
Bégaud, Bernard, et al.. (1985). [Drug surveillance as seen by the general practitioner. Apropos of a survey of 4175 physicians].. PubMed. 39(5). 453–7. 1 indexed citations
12.
Demotes‐Mainard, F., et al.. (1984). [Effect of age and sex on the pharmacokinetics of paracetamol].. PubMed. 39(4). 353–9. 7 indexed citations
13.
Albín, H, et al.. (1984). Effect of aluminium phosphate on the bioavailability of cimetidine and prednisolone. European Journal of Clinical Pharmacology. 26(2). 271–273. 7 indexed citations
14.
Albín, H, et al.. (1984). [Pharmacokinetics of oral theophylline in asthmatic patients on long-term corticoid therapy].. PubMed. 38(4). 333–9. 4 indexed citations
15.
Albín, H, et al.. (1983). [Pharmacokinetics of cimetidine in ascitic cirrhotics].. PubMed. 7(3). 251–5. 9 indexed citations
16.
Albín, H, et al.. (1981). [Adverse hepatitis effects and imputability (author's transl)].. PubMed. 36(4). 477–82. 2 indexed citations
17.
Albín, H, et al.. (1981). [Effect of temperature on the kinetics of propranolol, theophylline, phenytoin and digoxin in rats (author's transl)].. PubMed. 12(3). 229–38. 1 indexed citations
18.
Bégaud, Bernard, et al.. (1980). [Methods for identification and imputation of drug side effects. Side effects: a fleeing reality, an illusive reality? (author's transl)].. PubMed. 35(3). 287–92. 6 indexed citations
19.
Bégaud, Bernard, et al.. (1978). Imputabilité des effets indésirables des médicaments. Etude de 194 observations.. Therapies. 33(3). 4 indexed citations
20.
Bégaud, Bernard, et al.. (1978). [Determination of undesirable effects of drugs. Study of 194 case reports].. PubMed. 33(3). 383–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026